United States General Accounting Office Report
At the request of Sen. Howard Metzenbaum, the General
Accounting Office (GAO), an agency independent of the Executive
Branch, investigated the entire regulatory process over some ten
years which led to the Food and Drug Administration's approval of
aspartame as a safe food ingredient.
On June 18, 1987 the GAO's Executive Summary reported:
"FDA adequately followed its food
additive approval process in approving aspartame for marketing by
reviewing all of Searle's aspartame studies, holding a Public Board
of Inquiry to discuss safety issues surrounding aspartame's
approval, and forming a panel to advise the Commissioner."
"Furthermore, when questions were raised about
the Searle studies, FDA had an outside group of pathologists review
crucial aspartame studies. GAO found that throughout aspartame's
approval history, the FDA addressed safety issues raised internally
and by outside scientists and by concerned citizens."
18 June 1987